Second Time Lucky? Sumatriptan One Of Three Switches On The Cards In Germany

摘要

Germany’s Expert Committee for Prescription will consider three prescription-to-OTC switch applications at its next meeting on 27 June,including a second attempt at sumatriptan for migraines,as well as non-steroidal anti-inflammatories ketoprofen and liquid ibuprofen.The first prescription-to-OTC switch on the table at the next committee meeting is migraine and cluster headache medicine sumatriptan(50mg for oral use).This is not the first time this drug has been considered for switching by the committee.In 2012,the committee unanimously decided to recommend sumatriptan’s release from prescription status for migraines with and without aura in adults aged 18-65,after the initial diagnosis of migraine by a physician,as a 20mg nasal spray.